세계의 바이오뱅크 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Biobanking Market size is anticipated to grow from USD 3.84 Billion in 2024 to USD 10.73 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.07% during the forecast period of 2026 to 2033.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product &Service

• Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
• Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
• Services
• Software

By Sample Type

• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids
• Biological Fluids
• Human Waste Products

By Storage Type

• Manual Storage
• Automated Storage

By Ownership

• Universities
• National/Regional Agencies
• Non-Profit Organizations
• Private Organizations

By Application

• Regenerative Medicine
• Life Science Research
• Clinical Research

By End user

• Pharmaceutical & Biotechnology Companies and CROs
• Academic & Research Institutes
• Hospitals
• COMPANIES PROFILED
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Becton
• Dickinson and Company
• PHC Holdings Corporation
• Avantor Inc.
• Greiner Holding AG
• Azenta Inc.
• Tecan Trading AG
• Hamilton Company
• Cryoport Inc.
• Micronic
• AMSBIO
• Bay Biosciences LLC
• BioKryo
• SPT Labtech
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BIOBANKING INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product &Service
  • 3.7.2 Market Attractiveness Analysis By Sample Type
  • 3.7.3 Market Attractiveness Analysis By Storage Type
  • 3.7.4 Market Attractiveness Analysis By Ownership
  • 3.7.5 Market Attractiveness Analysis By Application
  • 3.7.6 Market Attractiveness Analysis By End user
  • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOBANKING MARKET ANALYSIS BY PRODUCT &SERVICE

• 5.1. Overview By Product &Service
• 5.2. Historical and Forecast Data Analysis By Product &Service
• 5.3. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Historic and Forecast Sales By Regions
• 5.4. Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Historic and Forecast Sales By Regions
• 5.5. Services Historic and Forecast Sales By Regions
• 5.6. Software Historic and Forecast Sales By Regions

6. GLOBAL BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE

• 6.1. Overview By Sample Type
• 6.2. Historical and Forecast Data Analysis By Sample Type
• 6.3. Blood Products Historic and Forecast Sales By Regions
• 6.4. Human Tissues Historic and Forecast Sales By Regions
• 6.5. Cell Lines Historic and Forecast Sales By Regions
• 6.6. Nucleic Acids Historic and Forecast Sales By Regions
• 6.7. Biological Fluids Historic and Forecast Sales By Regions
• 6.8. Human Waste Products Historic and Forecast Sales By Regions

7. GLOBAL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE

• 7.1. Overview By Storage Type
• 7.2. Historical and Forecast Data Analysis By Storage Type
• 7.3. Manual Storage Historic and Forecast Sales By Regions
• 7.4. Automated Storage Historic and Forecast Sales By Regions

8. GLOBAL BIOBANKING MARKET ANALYSIS BY OWNERSHIP

• 8.1. Overview By Ownership
• 8.2. Historical and Forecast Data Analysis By Ownership
• 8.3. Universities Historic and Forecast Sales By Regions
• 8.4. National/Regional Agencies Historic and Forecast Sales By Regions
• 8.5. Non-Profit Organizations Historic and Forecast Sales By Regions
• 8.6. Private Organizations Historic and Forecast Sales By Regions

9. GLOBAL BIOBANKING MARKET ANALYSIS BY APPLICATION

• 9.1. Overview By Application
• 9.2. Historical and Forecast Data Analysis By Application
• 9.3. Regenerative Medicine Historic and Forecast Sales By Regions
• 9.4. Life Science Research Historic and Forecast Sales By Regions
• 9.5. Clinical Research Historic and Forecast Sales By Regions

10. GLOBAL BIOBANKING MARKET ANALYSIS BY END USER

• 10.1. Overview By End user
• 10.2. Historical and Forecast Data Analysis By End user
• 10.3. Pharmaceutical & Biotechnology Companies and CROs Historic and Forecast Sales By Regions
• 10.4. Academic & Research Institutes Historic and Forecast Sales By Regions
• 10.5. Hospitals Historic and Forecast Sales By Regions

11. GLOBAL BIOBANKING MARKET ANALYSIS BY GEOGRAPHY

• 11.1. Regional Outlook
• 11.2. Introduction
• 11.3. North America Sales Analysis
  • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.3.2 North America By Segment Sales Analysis
  • 11.3.3 North America By Country Sales Analysis
  • 11.3.4 United States Sales Analysis
  • 11.3.5 Canada Sales Analysis
  • 11.3.6 Mexico Sales Analysis
• 11.4. Europe Sales Analysis
  • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.4.2 Europe By Segment Sales Analysis
  • 11.4.3 Europe By Country Sales Analysis
  • 11.4.4 United Kingdom Sales Analysis
  • 11.4.5 France Sales Analysis
  • 11.4.6 Germany Sales Analysis
  • 11.4.7 Italy Sales Analysis
  • 11.4.8 Russia Sales Analysis
  • 11.4.9 Rest Of Europe Sales Analysis
• 11.5. Asia Pacific Sales Analysis
  • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.5.2 Asia Pacific By Segment Sales Analysis
  • 11.5.3 Asia Pacific By Country Sales Analysis
  • 11.5.4 China Sales Analysis
  • 11.5.5 India Sales Analysis
  • 11.5.6 Japan Sales Analysis
  • 11.5.7 South Korea Sales Analysis
  • 11.5.8 Australia Sales Analysis
  • 11.5.9 South East Asia Sales Analysis
  • 11.5.10 Rest Of Asia Pacific Sales Analysis
• 11.6. Latin America Sales Analysis
  • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.6.2 Latin America By Segment Sales Analysis
  • 11.6.3 Latin America By Country Sales Analysis
  • 11.6.4 Brazil Sales Analysis
  • 11.6.5 Argentina Sales Analysis
  • 11.6.6 Peru Sales Analysis
  • 11.6.7 Chile Sales Analysis
  • 11.6.8 Rest of Latin America Sales Analysis
• 11.7. Middle East & Africa Sales Analysis
  • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 11.7.2 Middle East & Africa By Segment Sales Analysis
  • 11.7.3 Middle East & Africa By Country Sales Analysis
  • 11.7.4 Saudi Arabia Sales Analysis
  • 11.7.5 UAE Sales Analysis
  • 11.7.6 Israel Sales Analysis
  • 11.7.7 South Africa Sales Analysis
  • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE BIOBANKING COMPANIES

• 12.1. Biobanking Market Competition
• 12.2. Partnership/Collaboration/Agreement
• 12.3. Merger And Acquisitions
• 12.4. New Product Launch
• 12.5. Other Developments

13. COMPANY PROFILES OF BIOBANKING INDUSTRY

• 13.1. Top Companies Market Share Analysis
• 13.2. Market Concentration Rate
• 13.3. Merck KGaA
  • 13.3.1 Company Overview
  • 13.3.2 Company Revenue
  • 13.3.3 Products
  • 13.3.4 Recent Developments
• 13.4. Thermo Fisher Scientific Inc.
  • 13.4.1 Company Overview
  • 13.4.2 Company Revenue
  • 13.4.3 Products
  • 13.4.4 Recent Developments
• 13.5. Becton
  • 13.5.1 Company Overview
  • 13.5.2 Company Revenue
  • 13.5.3 Products
  • 13.5.4 Recent Developments
• 13.6. Dickinson And Company
  • 13.6.1 Company Overview
  • 13.6.2 Company Revenue
  • 13.6.3 Products
  • 13.6.4 Recent Developments
• 13.7. PHC Holdings Corporation
  • 13.7.1 Company Overview
  • 13.7.2 Company Revenue
  • 13.7.3 Products
  • 13.7.4 Recent Developments
• 13.8. Avantor Inc.
  • 13.8.1 Company Overview
  • 13.8.2 Company Revenue
  • 13.8.3 Products
  • 13.8.4 Recent Developments
• 13.9. Greiner Holding AG
  • 13.9.1 Company Overview
  • 13.9.2 Company Revenue
  • 13.9.3 Products
  • 13.9.4 Recent Developments
• 13.10. Azenta Inc.
  • 13.10.1 Company Overview
  • 13.10.2 Company Revenue
  • 13.10.3 Products
  • 13.10.4 Recent Developments
• 13.11. Tecan Trading AG
  • 13.11.1 Company Overview
  • 13.11.2 Company Revenue
  • 13.11.3 Products
  • 13.11.4 Recent Developments
• 13.12. Hamilton Company
  • 13.12.1 Company Overview
  • 13.12.2 Company Revenue
  • 13.12.3 Products
  • 13.12.4 Recent Developments
• 13.13. Cryoport Inc.
  • 13.13.1 Company Overview
  • 13.13.2 Company Revenue
  • 13.13.3 Products
  • 13.13.4 Recent Developments
• 13.14. Micronic
  • 13.14.1 Company Overview
  • 13.14.2 Company Revenue
  • 13.14.3 Products
  • 13.14.4 Recent Developments
• 13.15. AMSBIO
  • 13.15.1 Company Overview
  • 13.15.2 Company Revenue
  • 13.15.3 Products
  • 13.15.4 Recent Developments
• 13.16. Bay Biosciences LLC
  • 13.16.1 Company Overview
  • 13.16.2 Company Revenue
  • 13.16.3 Products
  • 13.16.4 Recent Developments
• 13.17. BioKryo
  • 13.17.1 Company Overview
  • 13.17.2 Company Revenue
  • 13.17.3 Products
  • 13.17.4 Recent Developments
• 13.18. SPT Labtech
  • 13.18.1 Company Overview
  • 13.18.2 Company Revenue
  • 13.18.3 Products
  • 13.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies